. Author manuscript; available in PMC: 2022 Oct 10.

Published in final edited form as: J Invest Dermatol. 2021 Sep 1;142(3 Pt A):594–602. doi: 10.1016/j.jid.2021.07.178

Table 1.

Summary of EC50s of human MRGPCRs (shown in μM) on β-defensin; n.d. indicates an EC50 that could not be estimated from the fitted data.

Mrgpr/peptide	X1	X2	X3	X4	D	E	F	G
DEFB103	0.28±0.05	0.42±0.11	7.4±1.9	n.d.	n.d.	n.d.	n.d.	n.d.
DEFB4	58.3±18	17.5±3.8	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.
Defb14	0.61±0.17